TrialCritical care (London, England)2010

Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock.

Marc O Maybauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.